Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2005-12-1
pubmed:abstractText
The paper provides evidence for the topicality of therapy for neuropathic pain syndrome (NPS) in cancer patients, describes the mechanisms of its occurrence, the specific features of its clinical manifestations, and presents a complex of currently available etiopathogenetic agents for the therapy of NPS. It also gives the authors' own data on the clinical application of the new anticonvulsant gabapentin (neurontin) in 34 patients with chronic NPS. The findings show the pronounced antineuropathic and analgesic effects of gabapentin in NPS. The side effects of the drug are not hazardous and they are moderately pronounced. These results are in agreement with the presented data of multicenter randomized placebo-controlled studies of the efficacy and tolerance of gabapentin in the treatment of cancer-induced NPS of various genesis.
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0201-7563
pubmed:author
pubmed:issnType
Print
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
33-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:articleTitle
[Neuropathic pain in oncology: mechanisms of its occurrence and current approaches to its treatment].
pubmed:publicationType
Journal Article, English Abstract